The TSC1 gene helps control when cells grow, divide, and make proteins, acting as one of the body’s natural brakes on cell growth. This gene plays an important role in keeping tissues organized, and when it does not work properly, cells can grow in an unbalanced way. Pathogenic variants in the TSC1 gene can cause tuberous sclerosis complex, a condition linked to noncancerous growths in organs such as the brain, skin, kidneys, heart, and lungs. Some people also have seizures, learning differences, or developmental delays.
What is a gene?
Genes are sections of DNA that give your cells instructions to make molecules or regulate processes in the body. Some genes carry the directions for building proteins, which are the parts of cells that do much of the work. Other genes mainly help govern when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
TSC1Gene function
What if the gene works
The TSC1 gene helps control how cells grow and divide. Its protein works with TSC2 to keep mTOR (a key cell growth signal) in balance, so cells respond appropriately to nutrients and other everyday cues.
Risk
What if the gene does not work
Pathogenic variants in the TSC1 gene can cause tuberous sclerosis complex, with benign growths in the brain, skin, kidneys, heart, and lungs. Effects range from mild to severe, influencing seizure risk, learning or behavior differences, and how early features appear.
Treatment
What does that mean for your treatment
A pathogenic loss-of-function variant in the TSC1 gene can make mTOR inhibitors such as everolimus or sirolimus relevant for selected TSC related problems. In practice, treatment is guided mainly by the affected organ and symptoms, not by choosing different medicines for TSC1 versus TSC2.
Conditions associated with TSC1
Gene function
What if the gene works
Your cells constantly decide when to grow, build, and conserve energy. The TSC1 gene helps manage these choices by working with the TSC2 gene to keep growth signals balanced. This is a central part of how the TSC1 gene helps control cell growth and energy use across many tissues.
The TSC1 gene helps keep cell growth at a measured pace. Working with the TSC2 gene, it helps restrain MTORC1 (a key growth control pathway).
By moderating MTORC1 (a key growth control pathway), the TSC1 gene helps control how strongly cells make new proteins. This keeps everyday building activity aligned with what the cell needs.
This gene helps cells match growth to the amount of energy and nutrients available. That steady adjustment supports normal function as conditions inside the body change.
The TSC1 gene also supports autophagy (the cell's recycling process). This helps cells reuse worn parts and maintain a balanced day to day supply of materials.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal differences among people, including appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TSC1 gene can weaken or remove hamartin, a protein that normally partners with TSC2, leading to less control over cell growth signaling. Missense variants may leave some protein stability or binding in place, while truncating, splice, or deletion variants often result in little or no working protein and a less stable TSC1-TSC2 complex. In the TSC1 gene variant spectrum linked to tuberous sclerosis complex, greater loss of function can contribute to earlier or more noticeable features, although severity varies from person to person.
How variants are linked to conditions
Pathogenic variants in the TSC1 gene cause tuberous sclerosis complex, an inherited condition that can affect the brain, skin, kidneys, heart, and lungs. In practical terms, this is how TSC1 gene variants are linked to tuberous sclerosis complex, with possible features including seizures, skin findings, developmental differences, and noncancerous growths in different organs. Symptoms can vary widely, even among relatives who carry the same variant.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For TSC1, risk is driven mainly by having a disease-causing variant in the gene, whether it is inherited from a parent or happens new in the family. The type and severity of symptoms can vary widely, even within the same family, and there is not enough evidence to say lifestyle changes lower the chance of developing the condition.
Inheritance of TSC1 variants
Variants in the TSC1 gene linked to tuberous sclerosis complex are inherited in an autosomal dominant pattern, which means a parent carrying the variant can pass it to a child with a 50% chance in each pregnancy. How variants of the TSC1 gene are inherited can also include a new, de novo variant, meaning the change starts in the child and was not inherited from either parent. Once a person carries a disease-causing TSC1 variant, they can pass it to sons or daughters equally.
What does my TSC1 result mean for my family?
Changes in the TSC1 gene are usually passed down in a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change and may want to discuss testing. Each child of someone with a disease-causing TSC1 change has a 1 in 2, or 50%, chance of inheriting it. Some cases happen for the first time in one person, so a parent does not always have the same gene change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for TSC1 variants usually uses a blood or saliva sample to read the TSC1 gene and look for changes in its DNA. Labs often combine sequencing with deletion and duplication analysis, which helps find both small variants and missing or extra pieces of the gene.
When should I consider getting a genetic test?
Consider TSC1 genetic testing if you or your child has signs of tuberous sclerosis complex, such as seizures, unusual skin spots, learning or behavior differences, or growths in the kidneys, brain, or lungs. Testing can also help when this condition runs in the family or to confirm a diagnosis.
A genetic result is only one part of your health story
Genetic test results can be informative, but how much they explain varies with the condition and the specific variant. Over time, the body is also shaped by factors including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic findings provide context rather than certainty and are best understood alongside the rest of a person’s care. In other situations, a result can give a clear answer. In areas like medication response, genetic results may help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Differences in how the body absorbs, breaks down, transports, or responds to a drug are common, and they can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape the way a person responds to medications. It studies the links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body processes it. This understanding can support treatment decisions that are more informed and more individualized. More information about this topic is available in the LearnHub.
Drugs influenced by the TSC1 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding everyday medication choices, so general concerns about symptoms or medicines are best discussed with your doctor. TSC1 has been studied in relation to medicines that act on the mTOR pathway, especially in tuberous sclerosis and some cancers, but this is still guided by the full clinical picture rather than a routine drug-response rule.
History
Tuberous sclerosis was recognized clinically in the 1800s, long before researchers knew which genes were involved. In the 1990s, scientists traced one cause of the condition to chromosome 9 and identified the TSC1 gene, marking an important step in understanding why the condition can run in families. Initially understood only through visible traits, later recognized as tied to a specific gene, this shift helped move care from description alone toward genetic confirmation. The discovery of the TSC1 gene came soon after work on the TSC2 gene, and together these findings clarified that tuberous sclerosis can result from changes in either gene. From these first observations, research expanded steadily. That progress helped shape modern genetic testing and family counseling for people affected by tuberous sclerosis.